Citius Oncology grants CFO 400,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Citius Oncology, Inc. (CTOR) granted Chief Financial Officer Jaime Bartushak 400,000 stock options on November 9, 2026, with an exercise price of $0.5495 per share and an expiration date of November 9, 2036. The award is subject to continuous service on applicable vesting dates. Bartushak also reported direct ownership of 825,000 common shares and direct option positions covering 400,000 shares at a $1.07 exercise price, expiring December 12, 2034, and 1,400,000 shares at $2.15, expiring July 5, 2033.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 400,000 | $0.00 | $0.00 |
| Holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. These options were granted on November 9, 2026. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- F2. These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- F3. These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
Key Figures
Key Terms
Continuous Service technical
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did CTOR CFO Jaime Bartushak receive?
What is the vesting schedule for CTOR CFO Jaime Bartushak's options?
AI-generated analysis. How Rhea-AI works. Not financial advice.